Theory and reality of antivirals against SARS-CoV-2

doi:10.12998/wjcc.v9.i23.6663

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6818)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

446

WORD

202

HTML

2816

Figures (1-2)

339

Tables (1-1)

249

Sum=4052

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

306

Download

776

Sum=1082

Publishing Process of This Article

Item

Count

Browse

511

Download

1173

Sum=1684

Aug 16, 2021 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Cases. Aug 16, 2021; 9(23): 6663-6673
Published online Aug 16, 2021. doi: 10.12998/wjcc.v9.i23.6663

Full Size Figure Download Figure

Figure 1 Schematic diagram of main antiviral targets[3,12,13,20,35,36,44,55,56]. IFN: Interferon; RBV: Ribavirin; CQP: Chloroquine phosphate.

Citation: Zhao B, Yang TF, Zheng R. Theory and reality of antivirals against SARS-CoV-2. World J Clin Cases 2021; 9(23): 6663-6673
URL: https://www.wjgnet.com/2307-8960/full/v9/i23/6663.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i23.6663